F
etal growth is monitored in pregnancies to ensure fetal well-being and to intervene in the context of maternal or fetal pathology, yet there are many challenges in distinguishing normal from abnormal growth. [1] [2] [3] Traditionally, cross-sectional fetal biometrics and estimated fetal weight (EFW), calculated using a formula with various combinations of fetal measurements, such as the head circumference, abdominal circumference, and femur length, are compared with reference sizefor-gestational-age curves to generate a percentile, with a range of 10th to 90th percentiles often considered appropriate for gestational age. 1, 4 The choice in reference will therefore affect the percentage of fetuses that are identified as small or large for gestational age (SGA or LGA; often defined as <10th or !90th percentiles, respectively). Regarding EFW, intrauterine estimates of fetal weight by ultrasound are highly (r ¼ 0.80e0.91) correlated with actual birthweight, although they can differ by !100 g and are more inaccurate at the extremes of EFW, <2000 g and >4000 g. 5 In theory then, birthweight references, whereby weight is measured directly as opposed to estimated, might seem preferable to assess fetal growth. However, birthweight-for-gestational-age reference percentiles inaccurately describe the preterm growth of fetuses who go on to deliver at term because infants who deliver preterm are more likely to be growth restricted. 6, 7 Therefore, intrauterine references, despite the drawbacks of estimating fetal weight from ultrasound measurements, tend to be preferred to birthweight references for clinical antepartum monitoring.
The Hadlock 1991 reference 8 that is commonly used in the United States included 392 white women from a single center in Texas where each fetus contributed a single ultrasound, limiting the ability to determine fetal growth prospectively. Until recently, longitudinal ultrasound-based references were based on relatively small studies comprising mostly white women, although larger studies existed outside the United States. 2 In light of critical data gaps about optimal fetal growth to aid clinical management of pregnant women, 3 longitudinal cohort studies were undertaken and provide new insights about contemporary fetal growth and how best to assess fetal growth: one in the United States, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Fetal Growth Studies 9,10 and 2 international, INTERGROWTH-21st (INTER-GROWTH) 11, 12 and World Health Organization (WHO) Multicentre Growth Reference Study (WHO Fetal). 13, 14 However, each has slightly different research aims that have an impact on the interpretation of the findings. We compare and contrast these 3 studies to aid in the application and clinical interpretation.
Approaches and assumptions
One of the main areas of dispute in the area of fetal and child growth is whether a single growth reference is representative of growth, regardless of ethnic or country origin. The INTERGROWTH 15 and the WHO Fetal 16 protocols started with the same premise of the WHO Multicentre Growth Reference Study (MGRS) 17 for infants and children, whose overarching aim was to create a single international growth reference for children aged 0e5 years. 18 Specifically, the WHO MGRS was predicated on the notion that infants and children of welloff parents and whose feeding met the WHO breast-feeding criteria represent optimal growth in size, and the WHO Fetal study was designed as a subsequent study to extend the WHO MGRS to the fetal period.
The INTERGROWTH and WHO Fetal studies on fetal growth started with the same assumption, that there would be no differences internationally in fetal growth when conditions were optimal. For the WHO MGRS, differences in length (0e2 years) and height (2e5 years) were evaluated among 6 countries: Brazil (South America), Ghana (Africa), India (Asia), Norway (Europe), Oman (Middle East), and the United States (North America). Without formal hypothesis testing, these differences were interpreted as small enough to not be meaningful, so the final decision was to create 1 child growth standard. 19 Additional measurements included head circumference, mideupper-arm circumference, triceps, and subscapular skinfolds, but differences across countries in these dimensions were not tested. INTERGROWTH evaluated for differences in crown-rump length (CRL), head circumference (HC), and newborn length among countries, concluding that the differences were small enough, before pooling. 20 However, comparison of child growth measurements, especially for head circumference, have demonstrated wide variability across countries 21 so the assumption that the small fetal differences do not reflect differences that will persist and be meaningful in infancy and childhood may need to reconsidered.
A key determinant of INTER-GROWTH's decision to pool across sites was whether the standardized site difference at different gestational ages was from a somewhat arbitrary range of e0.5 to 0.5 SD units. 20 Inappropriate interpretation of centiles could have resulted from pooling of sites given the allowed wide range of standardized site difference. To show this potential, our group previously calculated the probability of being below the lower limit of the standard for a particular site when the standard was constructed using data pooled across different sites for these values. 22 The probability of being less than the fifth centile varied according to the range of standardized site difference. Specifically, when the standardized site difference was 0.5, then 3.4% of fetuses (targeted centileepooled centile ¼ 5.0e1.6%) would have been misclassified as not extreme and 7.6% (targeted centileepooled centile ¼ 12. 6e5. 0%) of fetuses would have been misclassified as extreme.
INTERGROWTH reported the magnitude of within-and between-site variation, and some of the variances reported might be highly statistically significant. Furthermore, INTERGROWTH evaluated only CRL and HC. CRL is known to not vary as much, and HC also has less variation, as demonstrated in the results below. WHO Fetal was designed to create a pooled reference, although they evaluated for and showed country differences along with discussion of the implications. 13 The primary objective of the NICHD study was also to create optimal fetal growth standards. 23 Unlike the 2 
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Distribution of the EFW by race/ethnicity and gestation, NICHD Fetal Growth StudyeSingletons, INTERGROWTH-21st, and WHO Fetal for 24e40 weeks of gestation (A) and 36e40 weeks of gestation (B). Estimated third, 50th, and 97th percentiles for fetal weight by study; *note that values are the 2.5th and 97.5th percentiles for the WHO Fetal study. Also, NICHD and WHO Fetal calculated the EFW from HC, AC, and FL using the Hadlock 1985 Highly statistically significant racial/ ethnic differences in fetal growth were found, and by order of detection were as follows: humerus and femur lengths (beginning as early as 10 weeks), abdominal circumference (16 weeks), head circumference (21 weeks), and biparietal diameter (27 weeks) with racial/ethnic differences continuing throughout gestation, so racial/ethnicspecific curves were derived. 9 One of the continuing debates in designing and conducting an ultrasound or any physical growth study is how to select study subjects, and the terminology of reference vs standards. An ultrasound reference is a sample of pregnancies from a population and by definition contains high-risk pregnancies at risk for fetal growth restriction or overgrowth, including preexisting conditions and pregnancy complications.
An ultrasound standard includes fetuses at low risk for growth disturbances, with the goal of describing how all fetuses should grow, as opposed to traditional reference charts that describe how some have grown at a given place and time. However, distinguishing the normal from abnormal fetal growth remains a challenge, and the term standard in regard to fetal growth is controversial.
It is also important to note that because standards are variance restricted, their percentiles and interpretation are not the same as previous references. For example, the fifth percentile of a reference is not equivalent to the fifth percentile of a standard, in which fetuses are at lower risk for growth aberrations. It may be necessary to use more restrictive cut points, such as the 2.5th or 97.5th percentiles, for SGA or LGA, respectively. All 3 studies selected healthy women who were positioned for optimal fetal growth and had a known last menstrual period, although the specific inclusion and exclusion criteria varied. The cohort profiles of main differences for the 3 studies are presented in Figure 1 . One of the main differences was the racial/ 24  674  651  640  647  668  665   25  787  758  745  751  756  778   26  912  876  862  866  856  902   27  1050  1007  990  994  969  1039   28  1202  1151  1132  1134  1097  1189   29  1369  1311  1287  1289  1239  1350   30  1552  1486  1456  1459  1396  1523   31  1749  1676  1637  1642  1568  1707   32  1960  1879  1830  1837  1755  1901   33  2180  2090  2031  2040  1954  2103   34  2408  2307  2238  2247  2162  2312   35  2637  2521  2448  2452  2378  2527   36  2864  2731  2656  2654  2594  2745   37  3086  2935  2862  2854  2806  2966   38  3299  3134  3065  3054  3006  3186   39  3502  3330  3263  3256  3186  3403   40  3693  3525  3455  3466  3338 Another main difference was the exclusion of pregnancy complications and fetal factors such as congenital anomalies and stillbirth from the NICHD Study and INTERGROWTH, given the intention of creating standards; the NICHD defined additional a priori exclusion criteria or preterm delivery <37 weeks' gestation and karyotype abnormalities, neither of which was excluded from INTERGROWTH. WHO Fetal did not exclude pregnancies with complications, with the rationale that they wanted their study to be more of a reference. 13 The 3 studies used different statistical analytic approaches to model the fetal growth trajectories and calculate the corresponding percentiles. Both INTERGROWTH and NICHD assumed a parametric distribution of the fetal growth trajectories, under a linear mixed model, in which the methods used to create a smoothed mean trajectory differed slightly. After log transformation, the fetal growth data can be reasonably modeled by the linear mixedeffects models, assuming normally distributed random effects and error terms.
WHO Fetal used quantile regression to estimate percentiles directly and made somewhat fewer restrictive assumptions.
Despite different model assumptions and smoothing techniques, the approaches are flexible to capture the smooth fetal growth trajectories so that they should yield similar results when applied to the same fetal growth data set. In other words, any differences in results are unlikely due to the different methods used, although they have not been rigorously compared.
The analyses also adjusted for different covariates, which are not able to be summarized here because of the many analyses. For example, the WHO Fetal primary analyses did not adjust for country but secondary analyses adjusted for county and full interaction between country and gestational age. 13 Their EFW analyses adjusted for fetal sex, while the femur length analyses did not.
It WHO Fetal found country-specific differences similar to NICHD findings for race/ethnicity. Quantile regression with country as a covariate, and interaction terms with gestational age, demonstrated statistically significant variation in fetal growth among countries. For example, at term the fifth percentile for Norway was 3200 g, while it was 2700 g for Egypt and 2800 g using the pooled data from all countries, differences that were also apparent in birthweight. While acknowledging these differences, WHO Fetal chose to present a pooled standard with the rationale that the primary purpose of the study was to develop fetal standards to complement the WHO MGRS 17 for infants and children, aged 0e5 years.
Because differences in EFW are difficult to interpret in light of the different EFW formulas, we also compared fetal biometry among the 3 studies presented in Figures 3e5 and Tables 2-4 The differences in AC among studies paralleled that of EFW.
To directly compare the 2 EFW formulas, we used the NICHD data to calculate EFW using the Hadlock 1985 formula and INTERGROWTH formula ( Figure 6 ). The INTERGROWTH EFW formula performed very close to the NICHD Asian racial/ethnic group but differed from the 3 other racial/ ethnic groups. Additional application studies are needed in different populations to assess whether the INTERGROWTH EFW formula outperforms the Hadlock or other EFW formulas in identifying fetuses with other signs of compromise.
We also compared the NICHD EFW standards with the Hadlock 1991 reference 8 that is commonly used in clinical practice in the United States ( Figure 7 and Table 5 ). Interestingly, the NICHD white 50th percentile EFW was higher than the Hadlock reference, which also was in white women, but the other 3 NICHD racial/ethnic groups had EFW 50th percentiles lower than Hadlock. The population for Hadlock was limited to predominantly middle-class, white women without a history of maternal diseases associated with abnormal fetal growth and no congenital anomalies, so perhaps some of the differences between the white women could be explained by the NICHD cohort having even more restrictions and a healthier cohort, thereby including fetuses growing under more optimal conditions. Alternatively, the NICHD cohort included overweight women (body mass index [BMI] 25.0e29.9 kg/m 2 ) and only nonsmokers, and while body mass index was not reported by Hadlock et al, 8 the average BMI was lower in 1991 and smoking more common.
27,28 Increased maternal BMI is associated with larger birthweights, as is nonsmoking.
3 Nonetheless, perhaps the most important finding is that if the Hadlock 10th percentile is used to identify SGA in clinical practice, a larger percentage of fetuses from black, Hispanic, and Asian women would be labeled as SGA, while fewer fetuses from white women would be, compared with the NICHD standard.
These findings are similar to the NICHD analysis, which found the percentage of fetuses classified as being below the fifth percentile for EFW when using the white standard and was substantially higher for black, Hispanic, and Asian fetuses, except for black fetuses less than 18 weeks' gestation. For example, at 35 weeks' gestation, 15%, 12%, and 14% of black, Hispanic, and Asian fetuses, respectively, would have been classified as below the fifth percentile based on the white standard. 9, 10 Therefore, an additional 10% (15% minus 5%), 7% (12% minus 5%) and 9% (14% minus 5%) of black, Hispanic, and Asian fetuses, respectively, would be classified as extreme. Findings were also similar when a pooled standard was used. These findings are also similar to the potential for misclassification using the pooled standard in INTERGROWTH as previously demonstrated.
Implications
Despite having extensive inclusion and exclusion criteria aimed at enrolling healthy women with uncomplicated pregnancies, allowing for optimal fetal growth, none of the 3 studies observed consistent standards for population subgroups. INTERGROWTH observed country-of-origin level differences in maternal height and weight as did WHO Fetal, while the NICHD observed both racial/ethnic differences in maternal size and fetal growth.
Collectively, these data argue for racial/ethnic fetal growth standards. This argument is supported by the fact that size and body proportion differences are known to occur across different races/ ethnicities and countries for children and adults. 29 Mean stature for adult populations varies, and the ratio of sitting height to height, as a measure of body proportion, has also been shown to differ across 4 geographic areas including Australia/New Zealand/ Papua New Guinea, Africa, Europe, and Asia. 29 US blacks have been found to have a similar mean height compared with whites but are shorter in sitting height and longer in leg length. 30 Differences in body composition have also been found among different Asian ethnic groups, in which for the same BMI, Asian Indians had the highest percentage body fat compared with Malaysians and then Chinese, all of which were higher than whites. 25 This implies that the differences in fetal growth between the 2 international studies, INTERGROWTH and WHO Fetal, may be, to a large extent, an artifact of the international case mix (ie, maternal characteristics in the countries selected for the sample) and that, again, racial/ethnic-specific standards may improve the precision of fetal growth assessment.
In contrast to the assumption that all fetuses grow the same, INTER-GROWTH found in their study of neonatal anthropometry for healthy, low-risk, term deliveries, which included 4321 neonates from the fetal growth cohort plus 20,486 newborns from a cross-sectional cohort, wide variation in birthweight and HC among the countries, consistent with differences in maternal size. 31 For example, birthweight ranged (mean [SD]) from 2.9 (0.4) kg in India to 3.5 (0.5) kg in the United Kingdom and HC from 33.1 (1.1) cm to 34.5 (1.3) cm in India and the United Kingdom, respectively.
These differences in body size and proportion have been hypothesized to be explained by both environmental and genetic factors. 29 Using twin studies, heritability of birth size has been estimated to be up to 40%, with an intergenerational study finding that fetal genetic factors explained 31% of normal variation in birthweight and birth length, and maternal genetic factors explained 22% and 19% of normal variation in these measures, respectively. 32 ,33 Yet a complete knowledge of the determinants of fetal growth is not fully understood. 33, 34 It has been hypothesized that the interaction of environmental influences and genetic factors on fetal growth display developmental plasticity that explain phenotypic differences in fetal growth and birthweight, and under this paradigm, a universal fetal growth standard is elusive. 35, 36 In light of the many complexities underlying racial/ethnic definitions and the fact that it likely is not feasible to repeat these studies in individual populations across the world, it is important to understand how these study findings are applicable to individual populations. Ideally, a comparison of diagnostic accuracy, or misclassification rates, of SGA and LGA in relation to morbidity and mortality using different criteria is necessary to make recommendations and remains an important data gap. Identification for the appropriate percentiles is needed in local populations, depending on which standard is used.
Conclusion
Three recently completed longitudinal observational cohort studies, NICHD, When applying these standards to pregnant women under clinical management, it is important to be aware that different percentages of SGA and LGA will be identified and that the percentiles are not interpreted in the same manner as a reference. It might be helpful to use all tools on the belt, in which a simple application could be created to calculate the percentiles (or SD scores) for comparison among the 3 charts.
Also, the assessment of fetal growth with a 1-time measurement (ie, EFW below the 10th percentile at a given gestational age) remains standard clinical practice, despite recognition that a single measurement can indicate only size. At least 2 measurements separated in time are needed to estimate a trajectory, and perhaps one of the greater contributions of these prospective studies will be the ability to estimate fetal growth velocity. Ultimately, it is knowledge about fetal growth in addition to other factors (signs of placental dysfunction or maternal complications) and clinical judgment that should trigger intervention. 
